Provision Language
4. OBLIGATIONS OF BIOVAC
Biovac undertakes to:
[….]
4.6 In the event that Biovac develops and commercialises a Product that is responsive to a Public Health Emergency of International Concern as declared by WHO, to as soon as practically possible make available no less than ten percent of its real-time production capacity of Product for WHO and/or Public Sector Agencies at a price to be negotiated in good faith, but in no event to exceed its Cost of Production plus a twenty percent mark-up.